Key Documents
Christos E. Constantinou
- Emeritus Faculty, Acad Council, Urology
- Member, Bio-X
- Member, Cancer Center
Contact Information
- Clinical Offices
- Academic Offices
Personal Information Email ceconst@stanford.edu
Honors and Awards
- International Prize for Outstanding Contribution to Urology, CE Alken, Swizterland (1977)
Professional Education
- PhD, Stanford University Biomedical Engineering (1973)
- MS, Stanford University Biomedical Engineering (1968)
Research Interests
1. Pharmacologic methods in identifying alpha adrenergic receptors in the obstructed urinary tract.
2. Fluid mechanics and physiological mechanisms of contractility in the urinary tract.
3. Biomedical Engineering approaches in the characterization of static and dynamic properties of soft tissues.
4. Image processing and 3D reconstruction of magnetic resonance.
5. Computer models and vector analysis of pelvin floor musculature.
6. Software for interactive teaching.
Publications
- J Med Eng Technol. 2009; (4): 263-73
- Eur J Obstet Gynecol Reprod Biol. 2009; S159-65
- Neurourol Urodyn. 2009;
- Eur Urol. 2009;
- Stud Health Technol Inform. 2008; 390-5
- J Urol. 2008; (5): 1917-22
- Ultrasound Med Biol. 2007; (3): 342-52
- J Urol. 2007; (3 Pt 1): 970-7; quiz 1129
- Conf Proc IEEE Eng Med Biol Soc. 2007; 5803-6
- Physiol Meas. 2007; (11): 1429-50
- Neurourol Urodyn. 2007; (4): 458-63; discussion 464
- Ann N Y Acad Sci. 2007; 297-315
- Neurourol Urodyn. 2007; (3): 386-91
- Ann Biomed Eng. 2006; (3): 477-93
- IEEE Trans Ultrason Ferroelectr Freq Control. 2005; (3): 439-44
- Stud Health Technol Inform. 2005; 369-71
- Prostate. 2004; (2): 156-63
- TECHNOLOGY AND INFORMATICS MMVR(12). 2004; (12): 288-290
- Stud Health Technol Inform. 2004; 288-90
- Sensors and Actuators A. 2004; 278-285
- Eur J Pediatr Surg. 2004; (5): 303-15
- J Biomech. 2004; (1): 67-72
- APMIS Suppl. 2003; (109): 39-44
- Urology. 2003; (2): 474-8
- Neurourol Urodyn. 2003; (2): 164-75
- Ultrasound Med Biol. 2002; (9): 1157-63
- BJU Int. 2002; (4): 408-14
- J Urol. 2002; (4 Pt 1): 1458-63
- Neurourol Urodyn. 2001; (3): 287-95
- Urology. 2000; (2): 292-8
- BJU Int. 2000; (7): 879-85
- Life Sci. 1999; (23): PL 279-89
- Neurourol Urodyn. 1998; (3): 213-29
- Neurourol Urodyn. 1998; (1): 55-69
- J Urol. 1997; (6): 2361-5
- Neurourol Urodyn. 1997; (6): 567-81
- Neurourol Urodyn. 1996; (1): 85-101
- Prostate. 1996; (1): 30-5
- Neurourol Urodyn. 1996; (5): 513-27
- J Pharmacol Toxicol Methods. 1996; (4): 191-202
- Female Urol.. 1996; 115-131
- IEEE Trans Biomed Eng. 1995; (8): 843-8
- Neurourol Urodyn. 1995; (3): 209-16
- Intl. Urogynecol. J.. 1995; 138-152
- Int J Impot Res. 1995; (4): 221-31
- Br J Urol. 1994; (3): 337-40
- J Urol. 1993; (1): 159-64
- J Urol. 1992; (2 Pt 2): 559-63; discussion 564-5
- Urol Int. 1992; (3): 284-92
- Urol Int. 1992; (3): 278-83
- Urol Int. 1992; (1): 42-7
- Urol Int. 1992; (1): 35-8
- Urol Int. 1992; (3): 293-8
- Jpn J Pharmacol. 1992; 321P
- Jpn J Pharmacol. 1992; 384P
- J Pharmacol Toxicol Methods. 1992; (2): 119-26
- J Urol. 1992; (4): 1215-9; discussion 1219-20
- Int J Hyperthermia. 1991 Mar-Apr; (2): 367-83
- J Urol. 1991; (2 ( Pt 2)): 592-6
- J Urol. 1991; (5): 1434-40
- J Urol. 1991; (2): 433-8
- Am J Physiol. 1990; (3 Pt 2): R637-44
- J Urol. 1990; (4): 1015-7
- J Urol. 1990; (6): 1497-9
- Eur J Pharmacol. 1990; (3): 359-62
- J Urol. 1989; (3): 538-41
- Am J Physiol. 1989; (4 Pt 2): R781-7
- Am J Physiol. 1989; (4 Pt 2): R788-95
- J Urol. 1988; (1): 111-6
- Urol Int. 1988; (4): 211-8
- Phys Med Biol. 1987; (7): 823-33
- J Urol. 1986; (6): 1248-53
- Am J Physiol. 1986; (2 Pt 2): R225-30
- Urol Int. 1986; (3): 192-5
- Clin Obstet Gynaecol. 1985; (2): 343-56
- Urol Clin North Am. 1985; (2): 247-58
- J Urol. 1984; (1): 86-90
- Crit Rev Biomed Eng. 1982; (3): 229-64
- J Urol. 1982; (5): 964-9
- Urol Res. 1982; (6): 267-70
- J Urol. 1981; (1): 55-60
- Prog Clin Biol Res. 1981; 113-20
- Prog Clin Biol Res. 1981; 121-32
- Prog Clin Biol Res. 1981; 389-92
- Eur J Pharmacol. 1981; (1): 43-51
- Am J Physiol. 1981; (5): R398-411
- Am J Physiol. 1981; (5): R412-8
- Urol Int. 1981; (4): 256-64
- Urol Int. 1981; (4): 235-44
- Urol Int. 1980; (3): 161-6
- Urol Int. 1980; (1): 63-72
- Experientia. 1979; (6): 791-2
- Invest Urol. 1979; (2): 103-7
- Experientia. 1978; (5): 614-5
- Urol Int. 1978; (6): 399-416
- Invest Urol. 1977; (6): 440-1
- Invest Urol. 1976; (3): 233-40
- Experientia. 1976; (2): 266-7
- Urol Int. 1976; (6): 489-500
- Urol Int. 1976; (6): 476-88
- Experientia. 1975; (8): 931-3
- Urol Int. 1975; (5): 369-80
- Am J Physiol. 1974; (6): 1413-9
- Urol Int. 1974; (4): 265-79
- Urol Int. 1974; (6): 401-13
- Urol Int. 1974; (4): 249-64
- Invest Urol. 1972; (1): 56-62
- Invest Urol. 1972; (1): 14-8
- J Urol. 1971; (2): 209-13
- Invest Urol. 1971; (6): 645-54
- Invest Urol. 1971; (6): 655-72
- J Appl Physiol. 1970; (3): 396-7